Extensions

To provide a comprehensive analysis of US Patent 8630699, I will detail any patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and the projected expiration date, drawing upon information from the USPTO database.

Patent Term Adjustments (PTA)

Patent Term Adjustment (PTA) can be granted to a patent to compensate for administrative delays by the USPTO during prosecution. These delays fall into categories such as: "A delay" (e.g., USPTO failing to issue an office action within 14 months of filing, or responding to an applicant's reply within four months), "B delay" (the application pending for more than three years), and "C delay" (delays due to interference, secrecy orders, or appellate review). The total PTA is the sum of these delays, minus any overlapping periods and applicant-caused delays.

To determine the exact PTA for US Patent 8630699, direct access to the USPTO's Patent Center or the Patent Term Adjustment API with the application number (US13/488,520) would be necessary. The provided patent information indicates that applications filed after May 28, 2000, are subject to PTA rules. Since US8630699 was filed on June 5, 2012, it is eligible for PTA. Without specific PTA data from the USPTO for this patent, the exact adjustment amount cannot be stated here.

Patent Term Extensions (PTE)

Patent Term Extension (PTE) is granted under 35 U.S.C. § 156 to restore patent term lost due to premarket regulatory review for certain products, such as human drugs, medical devices, animal drugs, and food or color additives. Only one patent can be extended for a regulatory review period for any given product. PTE is distinct from PTA and is not affected by terminal disclaimers.

Given that US Patent 8630699 relates to a "body worn physiological sensor device having a disposable electrode module," it could potentially be eligible for PTE if a product covered by its claims underwent regulatory review by an agency like the FDA. Specifically, medical devices subject to review under section 515 of the Federal Food, Drug, and Cosmetic Act (FFDCA), which are Class III high-risk devices, are eligible for PTE. Without information on specific regulatory approval for a product covered by this patent, it's not possible to definitively state whether PTE has been applied or granted to US8630699. To determine this, one would typically need to consult the USPTO's lists of applications for patent term extension or certificates of extension, often found in Patent Center.

Continuation and Divisional Applications

The patent text explicitly states that US8630699 is a continuation application of, and claims priority and benefit to, U.S. Pat. No. 8,214,007 B2, entitled "Body Worn Device Having a Disposable Electrode Module," filed November 1, 2006.

The patent also lists several other patents and applications with priority dates related to US8630699. These likely represent continuation or divisional applications:

• Priority to US14/103,219 (publication of US8750974B2/en) on 2013-12-11.
• Priority to US14/268,666 (publication of US8965492B2/en) on 2014-05-02.
• Priority to US14/595,815 (publication of US9155484B2/en) on 2015-01-13.
• Priority to US14/880,413 (publication of US9433366B2/en) on 2015-10-12.
• Priority to US14/880,366 (publication of US20160029917A1/en) on 2015-10-12.
• Priority to US15/237,719 (publication of US9877663B2/en) on 2016-08-16.
• Priority to US15/880,712 (publication of US10159422B2/en) on 2018-01-26.
• Priority to US16/215,698 (publication of US10939839B2/en) on 2018-12-11.

These indicate a family of related patents and applications that build upon the original disclosure. A patent granted on a continuation or divisional application filed after June 8, 1995, will have a term ending twenty years from the filing date of the earliest application for which a benefit is claimed.

Related Family Members

As indicated above, US8630699 is a continuation of US8214007B2. The multiple priority claims listed above (US14/103,219, US14/268,666, US14/595,815, US14/880,413, US14/880,366, US15/237,719, US15/880,712, US16/215,698) are all related family members, likely representing additional continuation or divisional applications that stem from the same original subject matter or an earlier application in the priority chain.

Projected Expiration Date

The "Anticipated expiration" date listed in the patent details is November 1, 2026. This date is derived from the priority date of November 1, 2006, and the general rule that utility patents have a term of 20 years from the earliest filing date from which priority is claimed (in this case, the parent application US Pat. No. 8,214,007 B2).

This projected expiration date does not appear to include any potential Patent Term Adjustment (PTA) or Patent Term Extension (PTE). The USPTO does not calculate expiration dates for patents, but provides resources and calculators for estimation, considering factors like PTA, PTE, and terminal disclaimers. If PTA or PTE were granted, the actual expiration date could be later than November 1, 2026.